Elderly Clinical Trial - Assessment of Survival & Autonomy With Rituximab

Status Recruiting

Clinical Trial Summary

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Annual incidence increases with age and achieves more than 30 per 100 000 patients 65 years old or over. Despite high response rates with conventional regimen as R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone), 30% to 40% of patients develop a relapse or a refractory disease, with a poor prognosis. There is no standard chemotherapy in second line for elderly patients, which are not eligible to receive a salvage treatment by high-dose therapy followed by autologous stem cell transplantation. The median progression-free-survival (PFS) is less than one year with the most commonly used regimens including R-Gemcitabine-Oxaliplatin (R-GEMOX) and R-Bendamustine. One the other side, Rituximab plus Lenalidomide, an immunomodulatory agent, is an active new therapeutic approach, with an efficacy proved in a phase II trial with a patients with a prolonged disease-free-survival of 32 months for responders in patients with a median age of 74 years old. This combination is also efficient in the ABC phenotype DLBCL which is more common in elderly patients. For elderly patients, a management of the geriatric impairment together with lymphoma is required. Indeed, a comprehensive geriatric assessment detects frailty and vulnerability in elderly with a lymphoma and predicts severe treatment related toxicity, treatment settings and progression free survival. Moreover, geriatric intervention improved outcome, autonomy and quality of life. Functional status, assessed by Activities of patients Daily Living (ADL) is an independent predictive factor for feasibility of chemotherapy in elderly patients with cancer. The mini Data Set of DIALOG group is a new simplified geriatric assessment for oncologist.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Chemotherapy
Diffuse Large B-Cell Lymphoma (DLBCL), Nos
Elderly
Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse

Clinical Trial Details

NCT number	NCT04113226
Study type	Interventional
Source	Centre Hospitalier Universitaire, Amiens
Contact	Caroline Delette, MD
Phone	+33 3 22 45 59 14
Email	delette.caroline@chu-amiens.fr
Status	Recruiting
Phase	Phase 2
Start date	July 26, 2021
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05531396` - Agility Training on Physical Performance, Cognitive Function and Brain Activities in Elderly	N/A
Completed	`NCT03580447` - The Effect of Citrus Extract on Oxidative Stress	N/A
Recruiting	`NCT04096547` - Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
Completed	`NCT03339791` - Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial	N/A
Completed	`NCT03566719` - Effect of an Exercise Program on Risk of Fall in a Community Dwelling Older Adults	N/A
Completed	`NCT02138968` - Clinical and Economic Assessment of a Pre-frail Screening Program	N/A
Completed	`NCT01368029` - Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine	Phase 1
Not yet recruiting	`NCT01182961` - The Use of Virtual Reality for the Gait Training of Elderly Fallers	N/A
Completed	`NCT00961012` - The Big Squeeze (Lessening the Big Squeeze: The Effect of the Trunk Release on Interface Pressures of Individuals Seated in a High Fowler's Positions)	N/A
Completed	`NCT01899586` - Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly	N/A
Completed	`NCT00748683` - Development of an Integrated Health Care Environment for Elderly With RFID Technology	Phase 0
Completed	`NCT00533065` - Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone	N/A
Completed	`NCT00798668` - The Body's Response to Food Intake in Trained, Older Adults	N/A
Completed	`NCT00324701` - Telepsychology-Service Delivery for Depressed Elderly Veterans	N/A
Completed	`NCT00217113` - An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly	N/A
Completed	`NCT03666793` - Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care	N/A
Recruiting	`NCT06030804` - Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery	N/A
Recruiting	`NCT05014750` - Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
Completed	`NCT05021432` - Virtual Reality And Task Oriented Circuit Training Among Elderly Population	N/A
Active, not recruiting	`NCT04132492` - AGNES - Aging Nephropathy Study, a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma — Relyage

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms